Table 2.
Field | Summary of non-proteinuric diabetic nephropathy literature |
Prevalence | 57% of diabetic nephropathy patients |
Pathogenesis | Vascular and soluble elements, such as uric acid, TNFα, and VEGF, affecting renal microhemodynamics |
Diagnosis | (1) Increased renal resistive index; (2) Alterations in TNFα, TGF-β, endothelin, and other interleukins |
Treatment | (1) Enalapril; (2) Losartan; (3) Heparin; (4) Pentoxifylline |
TNFα: Tumor necrosis factor alpha; VEGF: Vascular endothelial growth factor; TGF: Transforming growth factor.